Volume 12, Number 10—October 2006
Research
Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children
Lisa A. Prosser*†
, Carolyn Buxton Bridges‡, Timothy M. Uyeki‡, Virginia L. Hinrichsen*†, Martin I. Meltzer‡, Noelle-Angelique M. Molinari‡, Benjamin Schwartz‡, William W. Thompson‡, Keiji Fukuda‡, and Tracy A. Lieu*†§
, Carolyn Buxton Bridges‡, Timothy M. Uyeki‡, Virginia L. Hinrichsen*†, Martin I. Meltzer‡, Noelle-Angelique M. Molinari‡, Benjamin Schwartz‡, William W. Thompson‡, Keiji Fukuda‡, and Tracy A. Lieu*†§Table A2
No. additional physician visits required to administer required doses, by age group
| Age group | No extra visits required | One extra visit required | Two extra visits required |
|---|---|---|---|
| 6–23 mo | 0.27 | 0.39 | 0.34 |
| 2 y | 0.26 | 0.57 | 0.17 |
| 3–4 y | 0.26 | 0.64 | 0.10 |
| 5–11 y | 0.25 | 0.75 | – |
| 12–17 y | 0.25 | 0.75 | – |
